HA-irino is a fantastic cancer drug with huge Market Potential...

HA-irino is a fantastic cancer drug with huge Market Potential .A Partnership for this drug could brng 50-100 Mil$ in upfront payment to Alchemia .

Again ACL is a pure GOLDMINE !!!!!
.....


I send an email to CEO regarding Nasdaq Listing see his answer below ....

Dear xxxxxxx,



Thanks for your message ? hopefully the news will start to propel the shareprice soon!

Regarding NASDAQ, I certainly believe that US investors will have a greater appreciation for our story. Their interest appears to be greatest for our oncology assets and I think that we will see buying interest once we start the phase III. A NASDAQ listing is certainly something we regularly consider although it is a balance between the potential increase in visibility/tradeability for our stock there versus the increased cost and burden of the Sarbanes-Oxley regulations. I assume from your question that it is a move that you would endorse?

Thanks again for your message

Best regards

Pete